Life Sciences
Synthetic Biology and Coronavirus: Preventing Future Pandemics
In this GEN webinar, sponsored by Codex DNA, our distinguished speaker, Dr. Silvi Rouskin, will focus much of her presentation on the biology of coronaviruses…
Broadcast Date: October 20, 2022
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
While COVID-19 may be entering the endemic phase in much of the world, having a greater understating of the underlying biology of coronaviruses is as essential now as it was when the pandemic first began. Furthermore, harnessing the advanced innovations that comprise much of the synthetic biology realm is critical to deciphering the inter-workings of this highly adaptable virus.
In this GEN webinar, our distinguished speaker, Dr. Silvi Rouskin, will focus much of her presentation on the biology of coronaviruses and how synthetic biology enables the study of coronavirus gene expression and recombination. This groundbreaking research ultimately aims to lead to a greater understanding of these processes while expediting the design of novel therapeutics and helping to prepare for future pandemics.
Join us to learn more about synthetic biology applications for nested genomes, frameshifting, discontinuous transcription, recombination in coronaviruses, and how an automated platform can optimize their build.
A live Q&A will follow the presentation, offering you a chance to pose questions to our expert panelist.
Produced with support from:
The post Synthetic Biology and Coronavirus: Preventing Future Pandemics appeared first on GEN – Genetic Engineering and Biotechnology News.
Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)
There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…
Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner
The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….